# Understanding the Immune Response to Two Different Meningitis Vaccines

> **NCT01593514** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 20 (actual)

## Conditions studied

- Meningitis
- Meningococcal Disease
- Septicaemia

## Interventions

- **BIOLOGICAL:** MenACWY-CRM conjugate vaccine (Menveo, Novartis)
- **BIOLOGICAL:** MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)
- **BIOLOGICAL:** MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)
- **BIOLOGICAL:** 1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)
- **BIOLOGICAL:** Polysaccharide (subcutaneously)-conjugate

## Key facts

- **NCT ID:** NCT01593514
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01593514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01593514, "Understanding the Immune Response to Two Different Meningitis Vaccines". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01593514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*